Farmax India Ltd
Farmax India Ltd, incorporated in India, listed on the Bombay Stock Exchange Limited, the company is engaged in Atta,pasta,vermicelli, maida,rawa
- Market Cap ₹ 2.67 Cr.
- Current Price ₹ 0.05
- High / Low ₹ /
- Stock P/E
- Book Value ₹ 0.42
- Dividend Yield 0.00 %
- ROCE -26.5 %
- ROE %
- Face Value ₹ 1.00
Pros
- Company has reduced debt.
- Stock is trading at 0.12 times its book value
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -27.3% over past five years.
- Company might be capitalizing the interest cost
- Debtor days have increased from 89.4 to 144 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: FMCG Industry: Food - Processing - Indian
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2006 | Mar 2007 | Aug 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
5.02 | 6.06 | 16.82 | 19.73 | 63.41 | 77.25 | 91.43 | 47.48 | 17.32 | 20.98 | 15.69 | 0.09 | |
4.28 | 5.27 | 14.61 | 17.68 | 54.96 | 69.82 | 86.04 | 64.58 | 18.34 | 22.58 | 24.15 | 0.17 | |
Operating Profit | 0.74 | 0.79 | 2.21 | 2.05 | 8.45 | 7.43 | 5.39 | -17.10 | -1.02 | -1.60 | -8.46 | -0.08 |
OPM % | 14.74% | 13.04% | 13.14% | 10.39% | 13.33% | 9.62% | 5.90% | -36.02% | -5.89% | -7.63% | -53.92% | -88.89% |
0.00 | 0.00 | 0.00 | 0.00 | -1.13 | 1.26 | 1.75 | -102.22 | 0.38 | 1.78 | 0.29 | 0.00 | |
Interest | 0.01 | 0.01 | 0.34 | 0.60 | 2.43 | 3.73 | 4.82 | 4.73 | 6.18 | 0.06 | 0.01 | 0.00 |
Depreciation | 0.36 | 0.36 | 1.37 | 0.78 | 1.67 | 2.45 | 4.76 | 2.54 | 2.02 | 2.22 | 1.60 | 1.18 |
Profit before tax | 0.37 | 0.42 | 0.50 | 0.67 | 3.22 | 2.51 | -2.44 | -126.59 | -8.84 | -2.10 | -9.78 | -1.26 |
Tax % | 37.84% | 38.10% | 36.00% | 37.31% | 24.22% | 14.34% | -24.59% | 0.57% | 0.00% | 0.00% | 0.00% | |
0.23 | 0.26 | 0.32 | 0.42 | 2.44 | 2.15 | -1.84 | -127.32 | -8.84 | -2.10 | -9.78 | -1.27 | |
EPS in Rs | 0.03 | 0.04 | 0.08 | -0.07 | -3.12 | -0.22 | -0.04 | -0.18 | -0.04 | |||
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 12% |
5 Years: | -27% |
3 Years: | -31% |
TTM: | -98% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 17% |
TTM: | 72% |
Stock Price CAGR | |
---|---|
10 Years: | -27% |
5 Years: | % |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | % |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2006 | Mar 2007 | Aug 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 3.22 | 3.22 | 11.00 | 11.00 | 12.60 | 25.83 | 25.83 | 40.83 | 40.83 | 53.42 | 53.42 |
Reserves | 0.55 | 0.81 | 13.58 | 14.00 | 18.84 | 316.17 | 75.03 | -45.69 | -54.53 | -52.61 | -62.39 |
0.00 | 0.00 | 9.01 | 11.18 | 16.13 | 37.20 | 30.07 | 35.38 | 41.49 | 41.02 | 41.00 | |
0.57 | 0.59 | 4.29 | 2.49 | 2.34 | 7.99 | 3.18 | 1.97 | 3.15 | 2.92 | 1.83 | |
Total Liabilities | 4.34 | 4.62 | 37.88 | 38.67 | 49.91 | 387.19 | 134.11 | 32.49 | 30.94 | 44.75 | 33.86 |
1.22 | 0.86 | 23.20 | 23.17 | 28.34 | 30.90 | 26.29 | 23.98 | 22.05 | 20.07 | 18.37 | |
CWIP | 0.00 | 0.00 | 0.00 | 2.43 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 1.11 | 1.15 | 1.15 | 1.15 | 0.00 | 253.34 | 0.34 | 0.00 | 0.00 | 0.00 | 0.00 |
2.01 | 2.61 | 13.53 | 11.92 | 21.57 | 102.95 | 107.48 | 8.51 | 8.89 | 24.68 | 15.49 | |
Total Assets | 4.34 | 4.62 | 37.88 | 38.67 | 49.91 | 387.19 | 134.11 | 32.49 | 30.94 | 44.75 | 33.86 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2006 | Mar 2007 | Aug 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | |
---|---|---|---|---|---|---|---|---|---|---|---|
-3.95 | -2.85 | -19.95 | -0.46 | -17.43 | -0.41 | ||||||
-325.82 | 1.26 | -3.78 | 0.42 | 1.56 | 1.22 | ||||||
330.23 | 1.58 | 23.79 | -0.03 | 16.09 | -4.06 | ||||||
Net Cash Flow | 0.46 | -0.01 | 0.06 | -0.07 | 0.22 | -3.25 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2006 | Mar 2007 | Aug 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 66.89 | 69.27 | 173.39 | 83.25 | 58.08 | 73.24 | 67.59 | 1.23 | 3.58 | 120.56 | 144.00 |
Inventory Days | 78.54 | 35.93 | 69.85 | 69.63 | 17.18 | 76.65 | 160.31 | 32.33 | |||
Days Payable | 36.05 | 5.33 | 10.66 | 3.94 | 2.19 | 36.04 | 45.10 | 23.00 | |||
Cash Conversion Cycle | 66.89 | 69.27 | 173.39 | 125.74 | 88.68 | 132.43 | 133.28 | 16.23 | 44.19 | 235.77 | 153.33 |
Working Capital Days | 95.98 | 110.22 | 194.22 | 166.87 | 108.04 | 122.66 | 131.14 | 8.23 | 8.43 | 280.62 | 188.43 |
ROCE % | 11.03% | 4.47% | 16.24% | 2.92% | 0.93% | -23.87% | -9.12% | -5.86% | -26.46% |
Documents
Announcements
- Standalone & Consolidated Financial Results, Limited Review Report for December 31, 2016 13 Feb 2017
- Board Meeting Intimation for Results & Closure of Trading Window 31 Jan 2017
- Shareholding for the Period Ended December 31, 2016 21 Jan 2017
- Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016 11 Jan 2017
-
Intimation of Subsidiary Closure
24 Dec 2016 - The Company has submitted closure letter of Farmax International FZE to RBI on December 08, 2016.